Tower Research Capital (TRC)’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$818K Buy
3,897
+2,837
+268% +$713K 0.02% 622
2025
Q4
$301K Sell
1,060
-858
-45% -$268K 0.01% 1145
2025
Q3
$592K Buy
1,918
+1,118
+140% +$350K 0.02% 755
2025
Q2
$251K Sell
800
-1,249
-61% -$360K 0.01% 1579
2025
Q1
$538K Sell
2,049
-1,283
-39% -$347K 0.02% 797
2024
Q4
$870K Buy
3,332
+1,323
+66% +$333K 0.02% 696
2024
Q3
$468K Sell
2,009
-14,687
-88% -$3.02M 0.01% 915
2024
Q2
$3.37M Buy
16,696
+12,059
+260% +$2.17M 0.06% 287
2024
Q1
$795K Sell
4,637
-3,893
-46% -$726K 0.02% 619
2023
Q4
$1.85M Buy
8,530
+659
+8% +$113K 0.02% 537
2023
Q3
$1.26M Buy
7,871
+3,745
+91% +$839K 0.04% 449
2023
Q2
$1.19M Sell
4,126
-4,639
-53% -$1.41M 0.04% 412
2023
Q1
$2.8M Buy
8,765
+8,238
+1,563% +$2.44M 0.09% 147
2022
Q4
$155K Buy
527
+520
+7,429% +$143K 0.01% 1485
2022
Q3
$2K Sell
7
-215
-97% -$53.8K ﹤0.01% 5599
2022
Q2
$49K Sell
222
-1,117
-83% -$254K ﹤0.01% 2901
2022
Q1
$356K Sell
1,339
-117
-8% -$28.7K ﹤0.01% 1362
2021
Q4
$388K Buy
1,456
+1,280
+727% +$371K 0.01% 1289
2021
Q3
$51K Sell
176
-8,563
-98% -$2.44M ﹤0.01% 2946
2021
Q2
$2.4M Buy
8,739
+8,388
+2,390% +$2.28M 0.06% 257
2021
Q1
$91K Sell
351
-4,074
-92% -$1.09M ﹤0.01% 2660
2020
Q4
$1.13M Buy
4,425
+1,064
+32% +$264K 0.03% 451
2020
Q3
$795K Buy
3,361
+2,425
+259% +$511K 0.01% 1200
2020
Q2
$182K Buy
+936
New +$179K 0.01% 1875
2019
Q4
Sell
-69
Closed -$11K 4189
2019
Q3
$11K Sell
69
-148
-68% -$20.8K ﹤0.01% 2877
2019
Q2
$26K Sell
217
-526
-71% -$53.9K ﹤0.01% 2013
2019
Q1
$71K Buy
+743
New +$63.7K ﹤0.01% 1594
2018
Q4
Sell
-576
Closed -$61K 4241
2018
Q3
$61K Sell
576
-4,838
-89% -$453K ﹤0.01% 1643
2018
Q2
$464K Buy
+5,414
New +$486K 0.03% 672
2018
Q1
Sell
-854
Closed -$59K 3711
2017
Q4
$59K Sell
854
-8,799
-91% -$577K 0.01% 1207
2017
Q3
$532K Buy
+9,653
New +$527K 0.04% 241
2017
Q2
Sell
-100
Closed -$4K 3272
2017
Q1
$4K Sell
100
-121
-55% -$5.19K ﹤0.01% 2336
2016
Q4
$8K Buy
221
+118
+115% +$4.4K ﹤0.01% 2784
2016
Q3
$4K Sell
103
-1,666
-94% -$65.9K ﹤0.01% 2703
2016
Q2
$54K Buy
1,769
+1,278
+260% +$39.8K 0.01% 1496
2016
Q1
$16K Buy
491
+245
+100% +$7.69K ﹤0.01% 1520
2015
Q4
$9K Sell
246
-2,073
-89% -$69.8K ﹤0.01% 2284
2015
Q3
$60K Buy
2,319
+1,336
+136% +$40.5K 0.01% 894
2015
Q2
$30K Sell
983
-4,399
-82% -$130K ﹤0.01% 1774
2015
Q1
$180K Buy
5,382
+5,282
+5,282% +$178K 0.02% 475
2014
Q4
$5K Sell
100
-435
-81% -$18.6K ﹤0.01% 2736
2014
Q3
$20K Sell
535
-239
-31% -$8.72K ﹤0.01% 2303
2014
Q2
$31K Buy
774
+716
+1,234% +$27.5K ﹤0.01% 1580
2014
Q1
$3K Buy
+58
New +$2.57K ﹤0.01% 3658
2013
Q4
Sell
-4,925
Closed -$179K 4835
2013
Q3
$179K Buy
4,925
+3,635
+282% +$122K 0.02% 826
2013
Q2
$41K Buy
+1,290
New +$36.5K ﹤0.01% 1095

Other funds holding PODD

Tower Research Capital (TRC)'s PODD Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Insulet (PODD) stake by 268% in Q1 2026, buying an estimated $713K and bringing the position to 3,897 shares worth $818K. The position accounts for 0.02% of the portfolio, ranked #622.

Tower Research Capital (TRC) first reported a position in PODD in Q2 2013 and has held it in 46 quarters since. The position peaked at $3.37M in Q2 2024. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Tower Research Capital (TRC) held 3,897 shares of Insulet worth $818K as of Q1 2026.
  • Tower Research Capital (TRC) bought 2,837 Insulet shares in Q1 2026, an estimated $713K.
  • Insulet made up 0.02% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #622 holding.
  • Tower Research Capital (TRC) first reported a position in Insulet in Q2 2013 and has held it in 46 quarters since.
  • Tower Research Capital (TRC)'s Insulet position peaked at $3.37M in Q2 2024.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.